Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 13 years
- Director since
- 2023
13 years of board service in total across 4 boards, counting each seat separately. Longest: Moderna Inc., 3 years.
Moderna Inc.
Director
Gilead Sciences Inc.
Director
Olema Pharmaceuticals Inc.
Director
Revolution Medicines Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Moderna Inc. May 6, 202681.0%
-
Gilead Sciences Inc. April 30, 202697.0%
-
Revolution Medicines Inc. June 26, 202585.5%
-
Gilead Sciences Inc. May 7, 202597.1%
-
Olema Pharmaceuticals Inc. June 13, 202487.2%
-
Gilead Sciences Inc. May 8, 202497.8%
-
Gilead Sciences Inc. May 3, 202398.1%
-
Moderna Inc. May 3, 202396.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Revolution Medicines Inc. | Grant or award | +1,191 | — | — |
| Apr 30, 2026 | Moderna Inc. | Option exercise | +16,233 | — | — |
| Apr 30, 2026 | Gilead Sciences Inc. | Grant or award | +1,146 | — | — |
| Jun 26, 2025 | Revolution Medicines Inc. | Grant or award | +3,142 | — | — |
| May 7, 2025 | Gilead Sciences Inc. | Grant or award | +1,516 | — | — |
| Apr 30, 2025 | Moderna Inc. | Option exercise | +979 | — | — |
| Jun 20, 2024 | Revolution Medicines Inc. | Grant or award | +4,800 | — | — |
| Nov 9, 2023 | Revolution Medicines Inc. | Grant or award | +52,291 | — | — |
| Nov 9, 2023 | Revolution Medicines Inc. | Grant or award | +27,696 | — | — |
| Nov 9, 2023 | Revolution Medicines Inc. | Grant or award | +10,500 | — | — |
| May 3, 2023 | Gilead Sciences Inc. | Grant or award | +1,887 | — | — |
| Apr 28, 2023 | Moderna Inc. | Option exercise | +670 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.